Supplementary Table 1 from Pharmacological Landscape of FDA-Approved Anticancer Drugs Reveals Sensitivities to Ixabepilone, Romidepsin, Omacetaxine, and Carfilzomib in Aggressive Meningiomas
<p>Drug Screening Data</p>
Gorde:
| Egile nagusia: | Gerhard Jungwirth (15047922) (author) |
|---|---|
| Beste egile batzuk: | Tao Yu (15047925) (author), Fang Liu (15047928) (author), Junguo Cao (15047931) (author), Montadar Alaa Eddine (15047934) (author), Mahmoud Moustafa (15047937) (author), Amir Abdollahi (15026702) (author), Rolf Warta (15047940) (author), Andreas Unterberg (15047943) (author), Christel Herold-Mende (15047946) (author) |
| Argitaratua: |
2025
|
| Gaiak: | |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|
Antzeko izenburuak
-
Elamipretide: First Approval
nork: Matt Shirley (7340599)
Argitaratua: (2025) -
Imlunestrant: First Approval
nork: Susan J. Keam (6594447)
Argitaratua: (2025) -
Data Sheet 1_LED light spectra influence the stimulation of mycelial growth and anticancer activity in Hericium erinaceus mycelium.pdf
nork: Preuk Chutimanukul (12463213)
Argitaratua: (2025) -
Male aggressiveness does not explain the frequency of reversed sexual cannibalism
nork: Narmin I. Beydizada (22680192)
Argitaratua: (2025) -
Table 1_In-silico pharmacological insights into the therapeutic potential of microRNAs for microplastic-associated cancers.docx
nork: Akmaral Baspakova (17961710)
Argitaratua: (2025)